Brief: Joint Q2 Revenue USD 13.3 Million Vs. IBES Estimate USD 13.3 Million

Joint

07/08/2025 21:05

Overview

Joint Q2 2025 revenue rises to $13.3 million, up 5% compared to Q2 2024.

Adjusted EBITDA rises 52% to $3.2 mln, reflecting operational improvements

Co refranchised 37 clinics, acquired Northwest regional developer territory

Outlook

Company revises 2025 system-wide sales forecast to $530 mln-$550 mln

New franchised clinic openings expected to be 30-35 in 2025

Result Drivers

REFRANCHISING STRATEGY - Refranchised 37 clinics, increasing franchised clinics to 92% of portfolio

REGIONAL EXPANSION - Acquired Northwest regional developer territory for $2.8 mln

MARKETING SHIFT - Pivoting marketing strategy towards pain relief to enhance brand campaign

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
$13.30 mln
Q2 Adjusted EBITDA
$3.20 mln


Press Release: ID:nGNX6rQgsv

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)